Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Adult (1)
- Age Factors (1)
- Aged (1)
- Allografts (1)
- Comorbidity (1)
-
- Disease-Free Survival (1)
- Female (1)
- Hawaiian monk seal (1)
- Hematology (1)
- Hematopoietic Stem Cell Transplantation (1)
- Humans (1)
- Lymphocyte Depletion (1)
- Male (1)
- Middle Aged (1)
- Neomonachus schauinslandi (1)
- Neoplasms (1)
- Reference intervals (1)
- Retrospective Studies (1)
- Risk Factors (1)
- Serum chemistry (1)
- Survival Rate (1)
- T-Lymphocytes (1)
Articles 1 - 2 of 2
Full-Text Articles in Life Sciences
Establishing Hematology And Serum Chemistry Reference Intervals For Wild Hawaiian Monk Seals (Neomonachus Schauinslandi), Angela C. Kaufman, Stacie J. Robinson, Dori L. Borjesson, Michelle Barbieri, Charles L. Littnan
Establishing Hematology And Serum Chemistry Reference Intervals For Wild Hawaiian Monk Seals (Neomonachus Schauinslandi), Angela C. Kaufman, Stacie J. Robinson, Dori L. Borjesson, Michelle Barbieri, Charles L. Littnan
United States Department of Commerce: Staff Publications
Hematology and serum chemistry reference intervals have been previously established for the endangered Hawaiian monk seal (Neomonachus schauinslandi) as an imperative measure for health assessments. Monitoring the health of the wild population depends upon reference intervals that are context specific; hence we developed reference intervals from fresh samples, as opposed to frozen, from wild monk seals. This study builds on the number of parameters from previous efforts by using samples collected between 2004 and 2015 from wild monk seals. Blood samples were analyzed by a single veterinary diagnostic laboratory within 24 hr of collection from apparently healthy, wild …
Age Adjusted Hematopoietic Stem Cell Transplant Comorbidity Index Predicts Survival In A T-Cell Depleted Cohort, Hayder Saeed, Swati Yalamanchi, Meng Liu, Emily Van Meter, Zartash Gul, Gregory Monohan, Dianna Howard, Gerhard C. Hildebrandt, Roger Herzig
Age Adjusted Hematopoietic Stem Cell Transplant Comorbidity Index Predicts Survival In A T-Cell Depleted Cohort, Hayder Saeed, Swati Yalamanchi, Meng Liu, Emily Van Meter, Zartash Gul, Gregory Monohan, Dianna Howard, Gerhard C. Hildebrandt, Roger Herzig
Markey Cancer Center Faculty Publications
Objectives: Allogeneic hematopoietic stem cell transplant (HCT) continues to evolve with the treatment in higher risk patient population. This practice mandates stringent update and validation of risk stratification prior to undergoing such a complex and potentially fatal procedure. We examined the adoption of the new comorbidity index (HCT-CI/Age) proposed by the Seattle group after the addition of age variable and compared it to the pre-transplant assessment of mortality (PAM) that already incorporates age as part of its evaluation criteria.
Methods: A retrospective analysis of adult patients who underwent HCT at our institution from January 2010 through August 2014 was …